Eli Lilly and Company

World Rank (Jan-05-2024)

10

Market Cap (Jan-05-2024)

586.387 Billion USD

World Rank (Jul-30-2023)

16

Market Cap (Jul-30-2023)

435.220 Billion USD

World Rank (Jan-07-2022)

39

Market Cap (Jan-07-2022)

248.240 Billion USD

World Rank (Jan-01-2021)

69

Market Cap (Jan-01-2021)

161.510 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 13

Headquarters Country

USA

Nasdaq / NYSE Code

LLY

Market Cap (Mar-08-2026)

934.24

CEO

David A. Ricks

Chairman

Juan R. Luciano

Founders

Eli Lilly

Employee Count

39,000

Employee Count as of Date

As on 2022

Headquarters City/State

Indiana

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

34,124 Million USD

Annual Operating Income in USD

10,787 Million USD

Annual Net Income in USD

5,240 Million USD

Annual Results for Period Ending

Dec-2023 ending year

Total Assets in USD

64,006 Million USD

Total Liabilities in USD

53,142 Million USD

Total Equity in USD

10,863 Million USD

Balance Sheet for Period Ending

Dec-2023 ending year

Business Sector

Company Website

Eli Lilly And Company - Pharmaceutical Company

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.

As of Jan-05-2024, Eli Lilly market cap was 586 Billion USD and it is World Top 10th rank company by market cap.

Facts About Eli Lilly as on 2022:

Approximately 39,000 employees worldwide
Clinical research conducted in more than 55 countries
Research and development facilities located in 8 countries
Manufacturing plants located in 8 countries
Products marketed in 120 countries

Facts About Company

As on 2022, Eli Lilly has 39,000 employees.

Eli Lilly annual revenue generated for period ending Dec-2022 was 28,541 million USD.

Eli Lilly annual net income generated for period ending Dec-2022 was 6,244 million USD.

Eli Lilly annual revenue generated for period ending Dec-2021 was 28,318 million USD.

Eli Lilly annual net income generated for period ending Dec-2021 was 5,581 million USD.

Annual Results Summary

Eli Lilly and Company - Annual Revenue and Net Profit - in Million USD:

Year - Ending	Revenue	Net Profit
Dec-2024	45,042	10,590
Dec-2023	34,124	5,240
Dec-2022	28,541	6,244
Dec-2021	28,318	5,581
Dec-2020	24,539	6,193
Dec-2019	22,319	8,318
Dec-2018	24,555	3,232
Dec-2017	22,871	-204 (Loss)
Dec-2016	21,222	2,737

Balance Sheet Summary

Eli Lilly and Company - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2024	78,714	64,443	14,271
Dec-2023	64,006	53,142	10,863
Dec-2022	49,489	38,714	10,775
Dec-2021	48,806	39,651	9,154
Dec-2020	46,633	40,807	5,641
Dec-2019	39,286	36,587	2,607
Dec-2018	43,908	32,999	9,829
Dec-2017	44,981	33,313	11,592
Dec-2016	38,806	24,725	14,008

Founded Year

1876

Institutional Investors

Top 30 Institutional Investors in ELI LILLY AND COMPANY as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	LILLY ENDOWMENT INC	09/30/2023	9,99,83,810	-10,45,000	-1.03%	$61,072,111
2	VANGUARD GROUP INC	09/30/2023	7,05,75,602	6,36,694	0.91%	$43,108,989
3	BLACKROCK INC.	09/30/2023	6,56,73,934	12,21,957	1.90%	$40,114,952
4	PNC FINANCIAL SERVICES GROUP, INC.	09/30/2023	5,17,89,291	-80,514	-0.16%	$31,633,935
5	STATE STREET CORP	09/30/2023	3,34,06,858	-4,71,559	-1.39%	$20,405,577
6	FMR LLC	09/30/2023	3,21,87,472	-6,89,613	-2.10%	$19,660,752
7	CAPITAL WORLD INVESTORS	09/30/2023	2,68,60,053	-7,528	-0.03%	$16,406,658
8	PRIMECAP MANAGEMENT CO/CA/	09/30/2023	2,30,63,536	-4,82,665	-2.05%	$14,087,669
9	PRICE T ROWE ASSOCIATES INC /MD/	09/30/2023	2,22,35,992	-19,24,967	-7.97%	$13,582,189
10	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	09/30/2023	1,71,57,660	-2,06,031	-1.19%	$10,480,242
11	JPMORGAN CHASE & CO	09/30/2023	1,58,03,192	16,63,578	11.77%	$9,652,906
12	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	1,57,14,225	5,08,724	3.35%	$9,598,563
13	WELLINGTON MANAGEMENT GROUP LLP	09/30/2023	1,28,54,465	-15,96,844	-11.05%	$7,851,764
14	MORGAN STANLEY	06/30/2023	1,24,68,075	3,05,630	2.51%	$7,615,750
15	NORTHERN TRUST CORP	09/30/2023	1,01,58,275	3,55,317	3.63%	$6,204,878
16	BANK OF AMERICA CORP /DE/	09/30/2023	98,37,955	-3,74,463	-3.67%	$6,009,220
17	NORGES BANK	12/31/2022	93,37,978	7,72,612	9.02%	$5,703,824
18	JENNISON ASSOCIATES LLC	09/30/2023	84,07,613	-1,73,825	-2.03%	$5,135,538
19	BANK OF NEW YORK MELLON CORP	09/30/2023	78,59,824	-5,79,799	-6.87%	$4,800,938
20	CAPITAL RESEARCH GLOBAL INVESTORS	09/30/2023	72,52,250	4,69,273	6.92%	$4,429,819
21	CAPITAL INTERNATIONAL INVESTORS	09/30/2023	61,39,754	-59,018	-0.95%	$3,750,285
22	LEGAL & GENERAL GROUP PLC	09/30/2023	59,24,805	-1,82,455	-2.99%	$3,618,989
23	NUVEEN ASSET MANAGEMENT, LLC	09/30/2023	52,74,778	1,74,753	3.43%	$3,221,940
24	ALLIANCEBERNSTEIN L.P.	09/30/2023	49,15,579	1,81,351	3.83%	$3,002,534
25	GOLDMAN SACHS GROUP INC	09/30/2023	48,39,056	-716	-0.02%	$2,955,792
26	FISHER ASSET MANAGEMENT, LLC	09/30/2023	44,57,074	2,18,773	5.16%	$2,722,470
27	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	44,35,311	88,016	2.03%	$2,709,177
28	AMUNDI	09/30/2023	44,01,713	-4,65,650	-9.57%	$2,688,654
29	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	43,72,782	-2,47,830	-5.36%	$2,670,983
30	AMERIPRISE FINANCIAL INC	09/30/2023	36,73,218	-4,32,630	-10.54%	$2,243,675